Finance

Lists
IVBXF:OTCMKTS
Innovent Biologics Inc
$13.11
+2.10%
(+0.27) 1D
Sep 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IVBXF...
Open
$13.00
High
$13.11
Low
$13.00
Mkt. cap
178.57B
Avg. vol.
1.52K
Volume
4.84K
52-wk high
$15.01
52-wk low
$9.10
Beta
0.07
Shares outstanding
1.74B
No. of employees
9K
Open
$13.00
High
$13.11
Low
$13.00
Mkt. cap
178.57B
Avg. vol.
1.52K
Volume
4.84K
52-wk high
$15.01
52-wk low
$9.10
Beta
0.07
Shares outstanding
1.74B
No. of employees
9K
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees8.75K
FoundedNov 28, 2011
Headquarters-
SectorBiotechnology
Websiteinnoventbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.54B
3.54B
4.31B
4.31B
Cost of goods sold
845.12M
845.12M
1.05B
1.05B
Cost of revenue
845.12M
845.12M
1.05B
1.05B
Research and development expenses
807.71M
807.71M
841.85M
841.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.91B
1.91B
1.86B
1.86B
Operating expense
2.72B
2.72B
2.71B
2.71B
Total operating expenses
3.56B
3.56B
3.76B
3.76B
Operating income
-19.96M
-19.96M
551.21M
551.21M
Other non operating income
45.19M
45.19M
150.87M
150.87M
EBT including unusual items
-29.10M
-29.10M
805.83M
805.83M
EBT excluding unusual items
-1.59M
-1.59M
805.83M
805.83M
Income tax expense
-18.72M
-18.72M
179.26M
179.26M
Effective tax rate
64.33%
64.33%
22.25%
22.25%
Other operating expenses
-
-
-
-
Net income
-10.38M
-10.38M
626.57M
626.57M
Net profit margin
-0.29%
-0.29%
14.54%
14.54%
Earnings per share
-
-
-
-
Interest and investment income
124.16M
124.16M
178.13M
178.13M
Interest expense
-9.17M
-9.17M
-20.46M
-20.46M
Net interest expenses
114.99M
114.99M
157.67M
157.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
140.29M
140.29M
695.34M
695.34M
Gain or loss from assets sale
-71.00K
-71.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps